Back to Woodline Partners LP Woodline Partners LP

KNSAKNSA

3 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Kiniksa Pharmaceuticals International, plc

No. Woodline Partners exited its KNSA (Kiniksa Pharmaceuticals International) position in Q1 2025. Its Q4 2024 13F listed 19,005 shares worth $375,919. Woodline Partners first reported KNSA in Q3 2024 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$850,385

Total Shares Change

-34,029

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$22.21
0
2024-Q4
Decreased
19,005
-44.1%
$375,9190.0%$19.78
0
2024-Q3
New
34,029
—
$850,3850.0%$24.99
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used